Comparison of the renal response of bortezomib-based induction and conventional regimen in multiple myeloma patients with renal failure

Main Article Content

Ahmet Sarici
Emin Kaya
Mehmet Ali Erkurt
Ilhami Berber
Lokman Hekim Tanriverdi
Omer Faruk Bahcecioglu
Selim Gok
Irfan Kuku

Abstract

Aim: Vincristine-doxorubicin-dexamethasone (VAD) was the commonly used first-line treatment for multiple myeloma (MM) patients with renal failure before bortezomib entered clinical practice. In this trial, we aimed to compare the effect of VAD and bortezomib-cyclophosphamide-dexamethasone (VCD) chemotherapy regimens on improving kidney function in MM patients with renal failure.
Materials and Methods: The records of MM patients in our center between January 2010 and February 2020 were retrospectively analyzed. Patients who received VAD or VCD as a first treatment chemotherapy protocol and whose initially estimated glomerular filtration rate (eGFR) was 50 mL/min/1.73 m2 and below were included in the study. Patients were divided into two groups according to the chemotherapy regimens they received.
Results: Sixty one MM patients (VAD: 26, VCD: 35) were included in the study. No significant difference was found between the VAD and VCD groups when the baseline, 1st and 2nd month eGFRs were compared (p>0.05). Overall renal response rate (at least minor response) in the VCD group at the end of the 1st month were higher than in the VAD group (p=0.002). Also, renal response rate in the VCD group at the end of the 2nd month were higher than in the VAD group (p=0.033).
Conclusion: In MM patients with renal insufficiency, overall renal response rates have increased with the use of VCD instead of VAD as a standard induction regimen.

Downloads

Download data is not yet available.

Article Details

How to Cite
Sarici, A., Kaya, E., Erkurt, M. A., Berber, I., Tanriverdi, L. H., Bahcecioglu, O. F., Gok, S., & Kuku, I. (2021). Comparison of the renal response of bortezomib-based induction and conventional regimen in multiple myeloma patients with renal failure. Annals of Medical Research, 28(10), 1824–1829. Retrieved from http://annalsmedres.org/index.php/aomr/article/view/3934
Section
Original Articles

Most read articles by the same author(s)

1 2 3 > >>